Bill Commons

MD HB 1051

died on adjournment

Public Health - Patient Access to Medication

Maryland · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did MD HB 1051 pass?

No. MD HB 1051 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-16): Hearing 3/05 at 1:00 p.m.

What is MD HB 1051 about?

MD HB 1051 is a bill in the 2026 Regular Session titled “Public Health - Patient Access to Medication”.

Who sponsors MD HB 1051?

Rosenberg is the primary sponsor of MD HB 1051.

Introduced
—
Latest action
2026-02-16 — Hearing 3/05 at 1:00 p.m.
Bill type
bill
Last updated
—

Sponsors

  • Rosenbergprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-02-16

    Hearing 3/05 at 1:00 p.m.

  2. 2026-02-16

    Hearing canceled

  3. 2026-02-13

    Hearing 2/26 at 1:00 p.m.

  4. 2026-02-09

    First Reading Health

    referral-committee

Versions

  • First - Public Health - Patient Access to MedicationCompare
  • (document, no version)Compare

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:23:32.621655Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MD&identifier=HB 1051. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.